Suscribete

Growth in Global Clinical Trial Landscape for PD-1/L1 Checkpoint Inhibitors

Cancer Research Institute has published a comprehensive analysis of the current clinical trial landscape of anti PD-1/L1 immune...

Global Immuno-Oncology Landscape Update Published

The Cancer Research Institute has published an updated global immuno-oncology landscape analysis highlighting a robust pipeline marked...

New international research collaboration explores blood-based biomarker testing

The study explores a potential non-invasive approach to identify tumor mutations.

Three Scientists to Receive Top Honors from CRI

Drs. Miriam Merad and Padmanee Sharma will be honored with the 2018 William B. Coley Award, while...

Regeneron and Perri Peltz to Receive the 2018 Oliver R. Grace Award

The Cancer Research Institute announced  that it will honor biotechnology company Regeneron, and journalist and filmmaker Perri...

FNIH and CRI Announce New Collaboration in Cancer Immunotherapy

FNIH has selected CRI to be its source of landscape intelligence in immuno-oncology.

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.